政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

国家药监局发文：77项医疗器械行业全新标准来了！

2021-05-27 rayms 国家药监局

医疗器械
关注

刚刚发布！

按照《医疗器械标准管理办法》《医疗器械标准制修订工作管理规范》要求，国家药监局组织开展了2021年医疗器械行业标准制修订项目遴选工作，经公开征求意见和组织专家论证，确定了2021年77项医疗器械行业标准制修订计划项目，现予公示。

该公示包括人工智能医疗器械、眼科仪器、牙科仪器以及医疗器械唯一标识与载体表示等77项行业标准亟待修订、制定！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935274, encodeId=0a0719352e44a, content=<a href='/topic/show?id=ab995841480' target=_blank style='color:#2F92EE;'>#新标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58414, encryptionId=ab995841480, topicName=新标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Sat Jan 01 19:40:22 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429277, encodeId=c87014292e76c, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968940, encodeId=a610968940e7, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65d55484096, createdName=汉水人家, createdTime=Thu May 27 16:09:45 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968855, encodeId=5126968855cd, content=强！！支持，大力支持！支持免费下载, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/f3c1afd9684a4278b7742cf6078f3d01/088bd137661a4e38a4117b7dc7478557.jpg, createdBy=2d945508172, createdName=ms6000000372388913, createdTime=Thu May 27 10:34:10 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2022-01-01 xiaoyang_ambs

    #新标准#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1935274, encodeId=0a0719352e44a, content=<a href='/topic/show?id=ab995841480' target=_blank style='color:#2F92EE;'>#新标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58414, encryptionId=ab995841480, topicName=新标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Sat Jan 01 19:40:22 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429277, encodeId=c87014292e76c, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968940, encodeId=a610968940e7, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65d55484096, createdName=汉水人家, createdTime=Thu May 27 16:09:45 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968855, encodeId=5126968855cd, content=强！！支持，大力支持！支持免费下载, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/f3c1afd9684a4278b7742cf6078f3d01/088bd137661a4e38a4117b7dc7478557.jpg, createdBy=2d945508172, createdName=ms6000000372388913, createdTime=Thu May 27 10:34:10 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-05-29 xuyu

    #药监局#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1935274, encodeId=0a0719352e44a, content=<a href='/topic/show?id=ab995841480' target=_blank style='color:#2F92EE;'>#新标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58414, encryptionId=ab995841480, topicName=新标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Sat Jan 01 19:40:22 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429277, encodeId=c87014292e76c, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968940, encodeId=a610968940e7, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65d55484096, createdName=汉水人家, createdTime=Thu May 27 16:09:45 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968855, encodeId=5126968855cd, content=强！！支持，大力支持！支持免费下载, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/f3c1afd9684a4278b7742cf6078f3d01/088bd137661a4e38a4117b7dc7478557.jpg, createdBy=2d945508172, createdName=ms6000000372388913, createdTime=Thu May 27 10:34:10 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-05-29 pyaili

    #国家药监局#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1935274, encodeId=0a0719352e44a, content=<a href='/topic/show?id=ab995841480' target=_blank style='color:#2F92EE;'>#新标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58414, encryptionId=ab995841480, topicName=新标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Sat Jan 01 19:40:22 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429277, encodeId=c87014292e76c, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968940, encodeId=a610968940e7, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65d55484096, createdName=汉水人家, createdTime=Thu May 27 16:09:45 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968855, encodeId=5126968855cd, content=强！！支持，大力支持！支持免费下载, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/f3c1afd9684a4278b7742cf6078f3d01/088bd137661a4e38a4117b7dc7478557.jpg, createdBy=2d945508172, createdName=ms6000000372388913, createdTime=Thu May 27 10:34:10 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-05-27 汉水人家

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1935274, encodeId=0a0719352e44a, content=<a href='/topic/show?id=ab995841480' target=_blank style='color:#2F92EE;'>#新标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58414, encryptionId=ab995841480, topicName=新标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4736501, createdName=xiaoyang_ambs, createdTime=Sat Jan 01 19:40:22 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429277, encodeId=c87014292e76c, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat May 29 00:40:22 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968940, encodeId=a610968940e7, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65d55484096, createdName=汉水人家, createdTime=Thu May 27 16:09:45 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968855, encodeId=5126968855cd, content=强！！支持，大力支持！支持免费下载, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/f3c1afd9684a4278b7742cf6078f3d01/088bd137661a4e38a4117b7dc7478557.jpg, createdBy=2d945508172, createdName=ms6000000372388913, createdTime=Thu May 27 10:34:10 CST 2021, time=2021-05-27, status=1, ipAttribution=)]
    2021-05-27 ms6000000372388913

    强！！支持，大力支持！支持免费下载

    0

相关资讯

真实世界证据可用于11种常见情形医疗器械临床评价

首届国家医疗器械临床使用专家委员会名单出炉！

5月10日，国家卫生健康委办公厅发布关于成立国家医疗器械临床使用专家委员会的通知。

2019年全国医疗器械主营收入达7200多亿元

中国药品监督管理研究会3日发布《中国医疗器械行业发展报告(2020)》。报告显示，2019年全国医疗器械主营收入达7200多亿元，同比增长12%。

Rapid Medical宣布任命James Romero为美洲区总裁

经验丰富的神经血管器械高管将领导美国、加拿大和拉丁美洲的商业化工作

国家药监局：92个医疗器械产品获批上市

2021年3月19日，国家药监局网站发布关于批准注册92个医疗器械产品的公告（2021年2月）（2021年第41号）。

《医疗器械监督管理条例》全文发布，自6月1日起施行

《医疗器械监督管理条例》已经2020年12月21日国务院第119次常务会议修订通过，现予公布，自2021年6月1日起施行。